top of page
All Posts
VB-008 in the Corneal Repair Landscape
VB-008 targets the corneal epithelium with a patient-derived cell-sheet, complementing other corneal repair options; early studies emphasize safety and workflow.
3 min read
Building a TMU-Licensed Platform for Patients
Built on TMU-licensed science and issued IP, Visionary BioMed’s cell-sheet platform is designed for disciplined clinical translation—starting with the cornea.
3 min read
Understanding Visionary BioMed’s Cell-Sheet Approach
Visionary BioMed grows a patient’s own epithelial cell-sheet to help restore the corneal surface; VB-008 is entering Phase 1 in Taiwan with a safety-first plan.
3 min read
bottom of page